Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids.
D000596:Amino Acids / Q000276:immunology* / Q000627:therapeutic use; D000818:Animals; D000941:Antigens; D003429:Cross Reactions; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000517:prevention & control; D006168:Guinea Pigs; D007166:Immunosuppressive Agents; D008213:Lymphocyte Activation; D004676:Myelin Basic Protein; D011108:Polymers; D012882:Skin Tests; D014364:Tryptophan
D000596:Amino Acids; D000941:Antigens; D007166:Immunosuppressive Agents; D004676:Myelin Basic Protein; D011108:Polymers; D014364:Tryptophan